Search Results - Katja Weisel

Refine Results
  1. 1

    Sarcopenia and fat loss from serial CT predict survival in multiple myeloma patients undergoing stem cell transplantation by Julian Kylies, Elias Brauneck, Matthias Priemel, Dominik Kylies, Katja Weisel, Leon-Gordian Leonhardt, Lennart Viezens

    Published in World Journal of Surgical Oncology (2025-09-01)
    Get full text
    Article


  2. 2

    P908: IDENTIFICATION OF CYTOKINES ASSOCIATED WITH RESPONSE AND CYTOKINE RELEASE SYNDROME – ANALYSIS OF MAGNETISMM-3 COHORT A by Katja Weisel, Nizar J Bahlis, Paula Rodríguez-Otero, Andrea Viqueira, Shen-Wu Wang, Sangeetha Sathiah, Douglas Robinson, Thomas O’brien, Hang Quach

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  3. 3

    Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unit by Panagiotis Karagiannis, Felix Klingler, Viktor Arelin, Winfried Alsdorf, Christina König, Kevin Roedl, Walter Fiedler, Katja Weisel, Stefan Kluge, Carsten Bokemeyer, Dominic Wichmann

    Published in Frontiers in Oncology (2025-01-01)
    Get full text
    Article


  4. 4

    P906: GENOMIC ANALYSIS TO IDENTIFY DETERMINANTS OF INHERENT RESPONSE AND RESISTANCE TO ELRANATAMAB IN MAGNETISMM-3 COHORT A by Paula Rodríguez-Otero, Hang Quach, Katja Weisel, Andrea Viqueira, Shen-Wu Wang, Phineas T. Hamilton, Tao Xie, Thomas O’brien, Nizar J Bahlis

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  5. 5

    PB2090: SYSTEMATIC LITERATURE REVIEW OF PROGNOSTIC FACTORS FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA by Shaji Kumar, Xavier Leleu, Katja Weisel, Rakesh Popat, Samantha Craigie, Leena Patel, Abril Oliva Ramirez, Wenzhen Ge, Qiufei MA, Christian Hampp, Sundar Jagannath

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  6. 6

    Correction: The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development by Pralay Mukhopadhyay, Hesham A. Abdullah, Joanna B. Opalinska, Prani Paka, Eric Richards, Katja Weisel, Suzanne Trudel, Maria-Victoria Mateos, Meletios Athanasios Dimopoulos, Sagar Lonial

    Published in Blood Cancer Journal (2025-03-01)
    Get full text
    Article


  7. 7

    The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development by Pralay Mukhopadhyay, Hesham A. Abdullah, Joanna B. Opalinska, Prani Paka, Eric Richards, Katja Weisel, Suzanne Trudel, Maria-Victoria Mateos, Meletios Athanasios Dimopoulos, Sagar Lonial

    Published in Blood Cancer Journal (2025-02-01)
    Get full text
    Article


  8. 8

    Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-... by Katja Weisel, Meletios A. Dimopoulos, Jesús San-Miguel, Agne Paner, Monika Engelhardt, Fiona Taylor, Jennifer Lord-Bessen, Christine Yip, Mike Greenwood, Jackson Tang, Michele Cavo

    Published in HemaSphere (2023-03-01)
    Get full text
    Article


  9. 9

    PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSION by Cesar Rodriguez Valdes, Katja Weisel, Rachid Baz, Akshanth Polepally, Jeremy A. Ross, Ziyi Jin, Kristin D’amico, Orlando F. Bueno, Leanne Lash Fleming, Peter Voorhees

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  10. 10

    Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells by Julia Hambach, Julia Hambach, William Fumey, William Fumey, Tobias Stähler, Anna Josephine Gebhardt, Anna Josephine Gebhardt, Gerhard Adam, Katja Weisel, Friedrich Koch-Nolte, Peter Bannas

    Published in Frontiers in Immunology (2022-05-01)
    Get full text
    Article


  11. 11

    Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making by Sebastian Gonzalez-McQuire, Meletios-Athanassios Dimopoulos, Katja Weisel, Walter Bouwmeester, Roman Hájek, Marco Campioni, Craig Bennison, Weiwei Xu, Krystallia Pantiri, Marja Hensen, Evangelos Terpos, Stefan Knop

    Published in MDM Policy & Practice (2019-01-01)
    Get full text
    Article


  12. 12

    P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD)... by Vania Hungria, Katja Weisel, Brooke Currie, Sue Perera, Neal Sule, Wei He, Astrid Mckeown, Sandhya Sapra, Linda Nelsen, Mary LI, Sophie Barale, Julia Boyle, Kaytlyn Mcpoyle, Meletios A. Dimopoulos

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  13. 13

    Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display by Steffen Krohn, Ammelie Svea Boje, Carina Lynn Gehlert, Sebastian Lutz, Nikos Darzentas, Henrik Knecht, Dietrich Herrmann, Monika Brüggemann, Axel J. Scheidig, Katja Weisel, Martin Gramatzki, Matthias Peipp, Katja Klausz

    Published in Frontiers in Immunology (2022-06-01)
    Get full text
    Article


  14. 14

    Hepatitis E virus infections in people with multiple myeloma: an emerging challenge in the era of immunotherapeutic approaches by Maximilian Al-Bazaz, Sven Pischke, Winfried Alsdorf, Piet Sonnemann, Sophia Cichutek, Julian Schulze zur Wiesch, Christoph Schaefers, Jule Artzenroth, Lisa Leypoldt, Abdulaziz Kamili, Carsten Bokemeyer, Katja Weisel, Ricardo Kosch

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  15. 15

    Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma by Niels Weinhold, Desiree Kirn, Anja Seckinger, Thomas Hielscher, Martin Granzow, Uta Bertsch, Gerlinde Egerer, Hans Salwender, Igor W. Blau, Katja Weisel, Jens Hillengass, Marc S. Raab, Dirk Hose, Hartmut Goldschmidt, Anna Jauch

    Published in Haematologica (2016-03-01)
    Get full text
    Article


  16. 16

    Measurable Residual Disease Testing in Multiple Myeloma Routine Clinical Practice: A Modified Delphi Study by Karthik Ramasamy, Hervé Avet-Loiseau, Cecilie Hveding Blimark, Michel Delforge, Francesca Gay, Salomon Manier, Joaquín Martinez-Lopez, Maria Victoria Mateos, Mohamad Mohty, Niels W.C.J. van de Donk, Katja Weisel

    Published in HemaSphere (2023-09-01)
    Get full text
    Article


  17. 17

    PB2133: TRIAL IN PROGRESS: LINKER-MM3, A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF LINVOSELTAMAB VERSUS ELOTUZUMAB, POMALIDOMIDE, AND DEXAMETHASONE (EPD) IN RELAPSED/REFRACTORY MULT... by Katja Weisel, Vania Hungria, Hang Quach, Sung-Soo Yoon, Paula Rodríguez-Otero, Glenn Kroog, Arijit Sinha, Anita Boyapati, Charlotte Lyon, Karen Rodriguez Lorenc, Timothy Inocencio, James Harnett, Lei Chi, Vygngley Moore, Peter Voorhees

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  18. 18

    Belantamab mafodotin does not induce B-cell maturation antigen loss or systemic immune dysfunction in multiple myeloma by Hanny Musa, Michał Mielnik, Suzanne Trudel, Katja Weisel, Taryn Mockus-Daehn, Geraldine Ferron-Brady, Qingqing Hong, Yinjiao Ma, Sagar Patel, Sunil Suchindran, Xiangdong Zhou, Paul G. Richardson, Adam D. Cohen, Daniel E. Lowther

    Published in Haematologica (2025-08-01)
    Get full text
    Article


  19. 19

    Multiple myeloma in the young: insights on prognosis, clinical features and treatment outcome derived from nationwide German registry data and a nested multicenter sample by Abdulaziz Kamili, Paymon Ahmadi, Lisa Leypoldt, Franziska Marquard, Christoph Schaefers, Ricardo Kosch, Frederik Peters, Henrik Kusche, Tanja Zamrik, Christine Hanoun, Maximilian Seib, Evgenii Shumilov, Theo Leitner, Cyrus Khandanpour, Carsten Bokemeyer, Katja Weisel, Susanne Ghandili

    Published in Haematologica (2024-07-01)
    Get full text
    Article


  20. 20

    Reduced alpha diversity of the oral microbiome correlates with short progression‐free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib‐based the... by Heinz Ludwig, Bela Hausmann, Martin Schreder, Wolfram Pönisch, Niklas Zojer, Stefan Knop, Eberhard Gunsilius, Alexander Egle, Andreas Petzer, Hermann Einsele, Roman Hajek, Katja Weisel, Karl Jochen Krenosz, Alois Lang, Daniel Lechner, Richard Greil, David Berry

    Published in eJHaem (2021-02-01)
    Get full text
    Article


Search Tools: